Announcements Trials
Browse Landscape

Status

Recruiting 5Completed 5Unknown 3Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other 2Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Obesity 23Overweight 11Weight Loss 7Neoplasms 7Breast Neoplasms 6Diabetes Mellitus, Type 2 5Pediatric Obesity 4Obesity, Morbid 4Motor Activity 4Sarcopenia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Obesity-Related Malignant Neoplasm 3Non-alcoholic Fatty Liver Disease 3Hypertension 3Diabetes Mellitus 3Colorectal Neoplasms 3Chemotherapy-induced Peripheral Neuropathy 3Sexual Dysfunction, Physiological 2Osteoporosis 2Metabolic Syndrome 2Metabolic Diseases 2Lymphoma, Follicular 2Inflammation 2Dyspnea 2Disease 2Digestive System Diseases 2Depression 2Death 2Cardiovascular Diseases 2Cancer-related Fatigue 2

Interventions

semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Qsymia 1Phentermine 1Naltrexone 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Diethylpropion 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Metabolic Syndrome × Other × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT03179657 2022-12-27

GNHS

Sun Yat-sen University

Active not recruiting
5,118 enrolled
Other

Cardiovascular Diseases, Death, Diabetes Mellitus, Type 2, Hypertension, Metabolic Diseases, Neoplasms, Nutrition Disorders, Obesity, Osteoporosis, Metabolic Syndrome, Renal Insufficiency, Chronic, Sarcopenia, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡